Log In
BCIQ
Print this Print this
 

BCR-ABL tyrosine kinase

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting BCR-ABL tyrosine kinase

BCIQ
Print ChartPrint this
0 0 1 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 6 4 5 0 5 1 0 1 0 0
Phases of DevelopmentPreclinicalPhase IPhase IIRegistrationMarketed
Autoimmune

1

0

1

0

0

Cancer

6

4

5

0

5

Cardiovascular

0

0

0

1

0

Hematology

0

0

0

0

1

Infectious

1

0

0

0

0

Neurology

2

0

0

0

0

Renal

0

0

1

0

0




 Products Targeting BCR-ABL tyrosine kinase
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

9

$163.7M

$233.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today